Vortioxetine eases depression in older adults, while cognitive gains stay mixed—showing selective boosts in attention and processing speed, not consistent global improvement.
|Slideshows|October 16, 2018
3 Must-Read Stories in Geriatric Psychiatry
Author(s)Mark L. Fuerst
A research roundup about long-term prescribing guidelines, “psychogenic death,” and implications for patients with depression and pain.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
The First Ever Treatment-Resistant Depression Awareness Day
2
What Makes Us Human? The Role of Psychiatry and the Future DSM
3
Antipsychotic Plasma Levels in Schizophrenia: Detecting Nonadherence and Guiding Dose Decisions
4
How Best to Manage Treatment-Resistant Depression
5